NAVIDEA BIOPHARMACEUTICALS

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) focuses on the development of innovative immunodiagnostic agents and immunotherapeutics to enhance patient care by identifying the sites and pathways of disease and enable better diagnostic accuracy, clinical decision-making, and targeted treatment. Patients and physicians, aspire to provide innovative immunodiagnostic agents and therapies to improve patient care for serious diseases. For investors, they aim to deliver superior growth through t... heir focus on developing their innovative Manocept™ platform and driving efficient business processes. For their employees, they provide a culture that focuses on the direct contributions their efforts make for the patients they serve and an innovative development environment for new breakthrough products.

#SimilarOrganizations #People #Financial #Event #Website #More

NAVIDEA BIOPHARMACEUTICALS

Social Links:

Facebook

Twitter

Industry:

Biopharma Biotechnology Health Care Health Diagnostics

Founded:

1983-01-01

Address:

Dublin, Ohio, United States

Country:

United States

Website Url:

http://www.navidea.com

Total Employee:

11+

Status:

Active

Contact:

614-822-2373

Email Addresses:

[email protected]

Total Funding:

101 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache

Similar Organizations

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

Current Advisors List

not_available_image

John K. Scott Vice Chair of the Board @ Navidea Biopharmaceuticals
Board_member
2021-07-01

eric-rowinsky_image

Eric Rowinsky Member of the Board of Directors @ Navidea Biopharmaceuticals
Board_member
2010-07-01

Current Employees Featured

michael-rosol_image

Michael Rosol
Michael Rosol Chief Medical Officer @ Navidea Biopharmaceuticals
Chief Medical Officer
2018-12-01

not_available_image

Brent L. Larson
Brent L. Larson Senior Vice President and CFO @ Navidea Biopharmaceuticals
Senior Vice President and CFO
2011-07-01

william-regan_image

William Regan
William Regan Chief Compliance Officer, Senior Vice President for Global Regulatory and Quality @ Navidea Biopharmaceuticals
Chief Compliance Officer, Senior Vice President for Global Regulatory and Quality
2014-03-01

michel-mikhail_image

Michel Mikhail
Michel Mikhail Chief Regulatory Officer @ Navidea Biopharmaceuticals
Chief Regulatory Officer
2021-10-01

malcolm-witter_image

Malcolm Witter
Malcolm Witter Director @ Navidea Biopharmaceuticals
Director
2020-12-01

Stock Details

Company's stock symbol is NYSEMKT:NAVB

Acquisitions List

Date	Company	Article	Price
2001-12-01	Cardiosonix	Cardiosonix acquired by Navidea Biopharmaceuticals	N/A

Investors List

john-k-scott_image

Key Employee Changes

Date	New article
2021-09-27	Navidea Biopharmaceuticals Appoints Michel Mikhail, Ph.D. as Chief Regulatory Officer

Official Site Inspections

http://www.navidea.com Semrush global rank: 4.99 M Semrush visits lastest month: 1.69 K

Host Informations
Whois Informations

Loading ...